Scientists At J. Craig Venter Institute Publish Draft Genome Sequence From Aedes Aegypti, Mosquito Responsible For Yellow Fever, Dengue Fever
Main Category: Tropical DiseasesAlso Included In: Infectious Diseases / Bacteria / Viruses; Biology / Biochemistry
Article Date: 18 May 2007 - 0:00 PDT
| Patient / Public: | ![]() |
3 (1 votes) |
| Healthcare Prof: | ![]() |
The fight against yellow fever and dengue fever was advanced today by an international team of researchers led by Vishvanath Nene, Ph.D. of the J. Craig Venter Institute who sequenced the Aedes aegypti genome, the mosquito that carries these deadly diseases. The research was published in the journal "Science."
This research is the first characterization of the approximately 1.38 billion base pairs of DNA of the Ae. aegypti genome. From this sequence, the team showed that this mosquito species has an estimated 15, 419 protein encoding genes.
Since both the sequence of the fruit fly, Drosophila melanogaster (sequenced in 1999 and published in 2000) and another mosquito species, Anopheles gambiae, (sequenced and published in 2002) were available, researchers were able to compare these insects to Ae. aegypti to ascertain biological differences between the species.
An. gambiae diverged on the evolutionary tree from the fruit fly about 250 million years ago, and the two mosquito species diverged from one another approximately 150 million years ago. Genomic comparisons revealed greater differences between the fruit fly and the mosquito species, than between the two mosquito species.
An important finding from this analysis is the discovery of certain proteins and genes unique to the Ae. aegypti. These proteins and genes, among many things, infer robustness to the insect. A more thorough analysis of these genes and proteins may lead to improved means to eradicate the mosquito and thereby stop the spread of yellow and dengue fevers.
Another key discovery was that almost 50 percent of the genome consisted of transposable elements. These are movable pieces of DNA that cause mutations and can affect genome size. The researchers showed that likely due to these elements the gene length and the intergenic regions of Ae. aegypti are 4-6 times larger than those of An. gambiae and the fruit fly.
"With more than half a million cases of dengue fever which is endemic in at least 100 countries and more than 30,000 deaths from yellow fever each year, clearly understanding the biology of the vector for these two worldwide killers is essential to eradicating these diseases," said Dr. Nene, principal investigator. "By having the genomic code of this species of mosquito we now have a key tool that will aid in the study of aspects of biology specific to Aedes aegypti. This will to help identify pathways which permit these mosquitoes to transmit viruses. Interfering with the function of critical mosquito molecules could lead to effective control of this prolific pest and the devastating diseases associated with it."
The scientists concluded that this draft genome will enable continued and more refined genomic maps of this disease vector. And, with other ongoing genome sequencing and analysis projects of related mosquito species, the spectrum of knowledge about these disease carriers grows, as does the potential to eliminate the associated diseases that kill millions each year.
This work was mainly funded by contracts from the United States National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). This research was first undertaken at The Institute for Genomic Research (TIGR), a legacy organization of the J. Craig Venter Institute, and in collaboration with The Broad Institute and VectorBase, a NIAID bioinformatics resource center. TIGR became part of the JCVI in October 2006.
About the J. Craig Venter Institute
The J. Craig Venter Institute is a not-for-profit research institute dedicated to the advancement of the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policymakers. Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 500 scientists and staff with expertise in human and evolutionary biology, genetics, bioinformatics/informatics, information technology, high-throughput DNA sequencing, genomic and environmental policy research, and public education in science and science policy. The legacy organizations of the JCVI are: The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA), the Joint Technology Center (JTC), and the J. Craig Venter Science Foundation. The JCVI is a 501 (c)(3) organization. For additional information, please visit http://www.JCVI.org.
J. Craig Venter Institute
http://www.JCVI.org
Visit our tropical diseases section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/71320.php>
APA
http://www.medicalnewstoday.com/releases/71320.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




